[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.120.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1983

Response of Psoriatic Nails to the Aromatic Retinoid Etretinate

Author Affiliations

2100 E Hallendale Beach Blvd Hallendale, FL 33009

New York

Arch Dermatol. 1983;119(8):627-628. doi:10.1001/archderm.1983.01650320001002

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor.—  In a letter to the editor in the August Archives (1982;118:535-536), Lindskov reported the nail findings in a patient receiving the aromatic retinoid etretinate for psoriasis. We report our results with retinoid treatment in two patients who had generalized psoriasis with prominent nail involvement.

Report of Cases.—Case 1.—  A 46-year-old man had extensive plaque-type psoriasis and the following nail changes: pitting, onycholysis, crumbling of the nail plate, proximal nail-fold involvement, and oil-drop change (Fig 1). The patient was receiving 0.5 to 1 mg/kg/day of oral etretinate. In terms of nail involvement, excellent improvement was noted in the crumbling of the nail plate and oil-drop change, and the onycholysis was responding well. Psoriatic involvement of the proximal nail fold improved moderately, and a fair response in the pitting was noted (Fig 2). The systemic side effects of the experimental drug included cheilitis, hair loss, itching, dryness,

First Page Preview View Large
First page PDF preview
First page PDF preview
×